// STATE LEGISLATION TRACKER

California SC R20: Relative to Peripartum Cardiomyopathy Awareness Month.

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Signed

State: California
Bill: SC R20
Session: 20252026
Filed: 2025-02-10
Read the bill: OpenStates →
Last reviewed: 2026-10-05

Plain-English Summary

California SCR20 is an awareness resolution designating February 2025 as Peripartum Cardiomyopathy Awareness Month. Based on the title, subjects, and available bill text, it does not regulate compounded peptides, prescribing, telehealth, clinician scope, FDA compounding, controlled substances, or prescription monitoring.

Key Points

No change to peptide access or prescribing rules
No compounding, 503A, or 503B provisions indicated
No telehealth or NP/naturopath scope change indicated
Mentions BNP/NT-proBNP testing, but not peptide therapies
Awareness-only resolution for a pregnancy-related heart condition

What to Watch For

Note This is a non-substantive awareness measure, not a health care practice or pharmacy regulation bill.

Note The BNP/NT-proBNP reference is diagnostic context for heart failure, not a peptide-access provision.

Note Future maternal-health bills could affect clinical workflows, but SCR20 itself does not.

Where the Bill Stands

The resolution was chaptered by the Secretary of State as Resolution Chapter 27, Statutes of 2025, so it is completed.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-11-04 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws